NCT02032836 - Comparative PK PD Study in PAH Patients (Fox vs. I-Neb) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2014

Primary Completion Date

January 7, 2015

Study Completion Date

September 29, 2017

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

lloprost(Ventavis,BAYQ6252, 20 µg/mL)

20 µg/mL iloprost nebulizer solution, inhaled with FOX nebulizer

DRUG

lloprost(Ventavis,BAYQ6252, 10 µg/mL)

10 µg/mL iloprost nebulizer solution, inhaled with I-Neb nebulizer

Trial Locations (6)

Graz

Hamburg

Giessen

Cologne

München

Würzburg